Skip to main content
Mosaic Biodata

Mosaic · Clara

What’s driving what, and where to intervene.

Health behaves like a complex system. Upstream drivers cascade into the downstream effects you can see on a panel. Read in isolation, root causes get missed. Here’s the case for reading the whole picture together, and why it’s finally possible.

  1. Data has outrun the clinician.

    A single patient now arrives with genomic variants, hormones, gut and oral microbiome, metabolic and cardiovascular panels, toxicology, mitochondrial markers, and biological-age clocks, often built up over years. It comes in as a stack of PDFs, each panel read on its own. But the body is one connected system, and no clinician, however expert, can hold every marker and every cross-panel interaction in mind at once.

  2. The insight lives in the connections.

    The clinical question was never only "what is abnormal." It is what is driving what, and where you intervene for the most impact. Health behaves like a complex system: upstream drivers cascade into the downstream effects you can see on a panel. Read in isolation, root causes get missed and interventions chase symptoms one lab at a time.

  3. Find the leverage points.

    Systems thinking looks for leverage: the one or few upstream drivers whose correction ripples through the whole picture. That is the pattern-finding that is hardest to do by hand across a dozen reports, and it is exactly what a tireless reader can surface for a clinician to weigh.

  4. Why now.

    Two things had to become true at once, and just did. The volume of a patient’s data finally exceeds what any clinician can integrate by hand, and AI became both capable enough to reason across domains and safe enough to run on real patient data under a Business Associate Agreement. Neither was true a couple of years ago.

The frame

Drivers, effects, and leverage.

Upstream drivers

The root causes: nutrient status, toxic load, methylation capacity, chronic stress, gut function. They rarely announce themselves; they show up as effects three panels away.

Downstream effects

The markers and symptoms you can see. Treating them one panel at a time chases the picture instead of changing it: the labs improve, then drift back.

Leverage points

The one or few upstream drivers whose correction ripples through the whole system. Finding them is the highest-value read, and the hardest to do across a dozen separate reports.

Clara is built to surface those leverage points for a clinician to weigh: a ranked differential of contributors and the intervention set that follows from it. It never makes the call; it makes the call clearer.

This is what Clara does.

Eleven domain specialists and a master systems analyst read across every interpreted report, and hand you a map of drivers, effects, and where to intervene.